Terminated NA INTERVENTIONAL 2-arm NCT01654328

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy (INOVATIO)

Sponsor: Prof. Dr. J. Wetzels

Conditions Radiographic Contrast Agent Nephropathy

Interventions Isotonic saline intravenously Sodium chloride tablets

Updated 6 times since 2017 Last updated: Mar 31, 2015 Started: Aug 31, 2012 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow inclusion

Other Radiographic Contrast Agent Nephropathy trials with similar outcome

NCT01168024 · Phase NA · Nov 2013

Browse all Radiographic Contrast Agent Nephropathy trials

Listed as NCT01654328, this NA trial focuses on Radiographic Contrast Agent Nephropathy and remains terminated or withdrawn. Sponsored by Prof. Dr. J. Wetzels, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Mar 2022 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Mar 2022 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prof. Dr. J. Wetzels

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands